Case Reports in Oncological Medicine (Jan 2017)

Chinese Medicine Treatment for Afatinib-Induced Paronychia

  • Pei-Yuu Yang,
  • Chen-Jei Tai

DOI
https://doi.org/10.1155/2017/7327359
Journal volume & issue
Vol. 2017

Abstract

Read online

Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient’s condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.